1. Home
  2. APYX vs MCRB Comparison

APYX vs MCRB Comparison

Compare APYX & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apyx Medical Corporation

APYX

Apyx Medical Corporation

HOLD

Current Price

$3.48

Market Cap

128.0M

Sector

Health Care

ML Signal

HOLD

Logo Seres Therapeutics Inc.

MCRB

Seres Therapeutics Inc.

HOLD

Current Price

$8.99

Market Cap

139.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APYX
MCRB
Founded
1982
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
128.0M
139.7M
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
APYX
MCRB
Price
$3.48
$8.99
Analyst Decision
Strong Buy
Hold
Analyst Count
3
3
Target Price
$6.67
$14.33
AVG Volume (30 Days)
70.1K
88.7K
Earning Date
06-01-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
19.40
100.00
EPS
N/A
2.40
Revenue
N/A
$126,325,000.00
Revenue This Year
$9.36
N/A
Revenue Next Year
$6.70
N/A
P/E Ratio
N/A
$3.73
Revenue Growth
N/A
1672.24
52 Week Low
$0.83
$0.36
52 Week High
$4.50
$29.98

Technical Indicators

Market Signals
Indicator
APYX
MCRB
Relative Strength Index (RSI) 44.25 36.75
Support Level $3.25 $6.99
Resistance Level $4.40 $16.14
Average True Range (ATR) 0.20 0.57
MACD -0.01 0.25
Stochastic Oscillator 35.37 62.10

Price Performance

Historical Comparison
APYX
MCRB

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

Share on Social Networks: